Literature DB >> 11689147

Clinical evaluation of human telomerase catalytic subunit in bladder washings from patients with bladder cancer.

T Fukui1, N Nonomura, T Tokizane, E Sato, Y Ono, Y Harada, K Nishimura, S Takahara, A Okuyama.   

Abstract

PURPOSE: We examined the expression of mRNA of human telomerase reverse transcriptase (hTERT), a catalytic subunit of the telomerase complex, in bladder washings as a tumor marker for the detection of bladder cancer.
MATERIALS AND METHODS: Bladder washings were obtained from 63 patients. We examined the expression of hTERT mRNA by the nested reverse transcription-polymerase chain reaction (RT-PCR) method and also measured the relative expressions of hTERT mRNA and beta(2)-microglobulin (beta(2)-MG) in these samples by RT-PCR analysis. Correlations between the relative expression of hTERT mRNA and clinical features were analyzed. We also compared the sensitivity of this assay with that of urinary cytology.
RESULTS: By nested RT-PCR, we detected three false-positive cases (11%) in the control group. Therefore, the relative expression values of hTERT mRNA and beta(2)-MG correlated strongly with tumor size, but not with multiplicity or histologic grade. When the cut-off value of the expression was fixed at 0.27%, the sensitivity and specificity of this assay were 74% and 93%, respectively. This assay was more sensitive than urinary cytology for the detection of bladder cancer.
CONCLUSION: These results suggest that the relative expression of hTERT mRNA in bladder washings is useful in screening for bladder cancer. Relative expression is of assistance in diagnosing bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689147     DOI: 10.1089/109153601750124249

Source DB:  PubMed          Journal:  Mol Urol        ISSN: 1091-5362


  3 in total

Review 1.  Early bladder cancer: concept, diagnosis, and management.

Authors:  Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Int J Clin Oncol       Date:  2006-02       Impact factor: 3.402

2.  Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.

Authors:  Letizia Mezzasoma; Cinzia Antognelli; Chiara Del Buono; Fabrizio Stracci; Emanuele Cottini; Giovanni Cochetti; Vincenzo N Talesa; Ettore Mearini
Journal:  BMC Urol       Date:  2010-10-04       Impact factor: 2.264

3.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.